<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Acute otitis media in children: Epidemiology, microbiology, and complications
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Acute otitis media in children: Epidemiology, microbiology, and complications
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Acute otitis media in children: Epidemiology, microbiology, and complications
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen I Pelton, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paula Tähtinen, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Glenn C Isaacson, MD, FAAP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 02, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute otitis media (AOM) is defined by moderate to severe bulging  (
         <a class="graphic graphic_picture graphicRef63268" href="/z/d/graphic/63268.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef127414" href="/z/d/graphic/127414.html" rel="external">
          picture 2
         </a>
         ) of the tympanic membrane or new onset of otorrhea not due to acute otitis externa accompanied by acute signs of illness and signs or symptoms of middle ear inflammation [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6009.html" rel="external">
          "Acute otitis media in children: Clinical manifestations and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         The risk factors, microbiology, clinical features, and complications of AOM will be reviewed here. Related topics are presented separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="medical medical_review" href="/z/d/html/6009.html" rel="external">
          Acute otitis media in children: Clinical manifestations and diagnosis
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          Acute otitis media in children: Treatment
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="medical medical_review" href="/z/d/html/5998.html" rel="external">
          Acute otitis media in children: Prevention of recurrence
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="medical medical_review" href="/z/d/html/5966.html" rel="external">
          Otitis media with effusion (serous otitis media) in children: Clinical features and diagnosis
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="medical medical_review" href="/z/d/html/87008.html" rel="external">
          Otitis media with effusion (serous otitis media) in children: Management
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="medical medical_review" href="/z/d/html/6866.html" rel="external">
          External otitis: Pathogenesis, clinical features, and diagnosis
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="medical medical_review" href="/z/d/html/6872.html" rel="external">
          Acute otitis media in adults
         </a>
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         AOM is a leading cause of acute care visits and the most common reason for administration of antibiotics in children [
         <a href="#rid2">
          2-4
         </a>
         ].
        </p>
        <p>
         AOM is slightly more common in males than females [
         <a href="#rid5">
          5-7
         </a>
         ]. It occurs at all ages but is most prevalent between 6 and 24 months of age, after which it begins to decline [
         <a href="#rid8">
          8
         </a>
         ]. AOM is infrequent in school-age children, and adolescents. Children who have their first episode of AOM before age six months (ie, "early-onset AOM") are at increased risk for recurrent AOM [
         <a href="#rid5">
          5,6,8
         </a>
         ]. Children who have few or no episodes of AOM before age three years are unlikely to have subsequent recurrent AOM. (See
         <a class="medical medical_review" href="/z/d/html/5998.html" rel="external">
          "Acute otitis media in children: Prevention of recurrence", section on 'Factors influencing choice'
         </a>
         .)
        </p>
        <p>
         The incidence of AOM in children in the United States decreased following universal immunization of infants with the 7-valent pneumococcal conjugate vaccine (PCV7) in 2000 and further declined after PCV7 was replaced with the
         <a class="drug drug_pediatric" data-topicid="15567" href="/z/d/drug information/15567.html" rel="external">
          13-valent pneumococcal conjugate vaccine
         </a>
         (PCV13) in 2010 [
         <a href="#rid3">
          3,9-13
         </a>
         ]. In a prospective longitudinal cohort of 615 children &lt;4 years from the post-PCV era (2006 to 2016), the cumulative incidence of ≥1 episode of AOM (confirmed by two validated otoscopists) was 23 percent at ≤1 year, 42 percent at ≤2 years, and 60 percent at ≤4 years [
         <a href="#rid6">
          6
         </a>
         ]. In the classic study from the pre-PCV era (1989), the cumulative incidence of ≥1 episode of AOM was 62 percent at ≤1 year and 83 percent at ≤3 years [
         <a href="#rid5">
          5
         </a>
         ]. A shift to more stringent diagnostic criteria for AOM between the pre-PCV7 and post-PCV13 eras also may have contributed to the decline in incidence [
         <a href="#rid1">
          1,14
         </a>
         ].
        </p>
        <p>
         The incidence of AOM in children also declined in other countries after introduction of pneumococcal conjugate vaccines to the routine immunization schedule [
         <a href="#rid15">
          15-19
         </a>
         ]. Social distancing and other measures to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the onset of the coronavirus 2019 (COVID-19) pandemic resulted in the decrease of all respiratory tract infections, including AOM [
         <a href="#rid20">
          20-22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          RISK AND PROTECTIVE FACTORS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – A number of risk factors for AOM have been established, the most of important of which is age.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Age
         </strong>
         – The age-specific attack rate for AOM peaks between 6 and 12 months of age [
         <a href="#rid6">
          6
         </a>
         ]. After that, the incidence declines with age, although there is a small increase between five to six years (the time of school entry). AOM is infrequent in school-age children and adolescents. (See
         <a class="medical medical_review" href="/z/d/html/6872.html" rel="external">
          "Acute otitis media in adults", section on 'Epidemiology of acute otitis media'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The prevalence of AOM in early life is probably related to multiple factors, including immature anatomy (eg, in infants, the Eustachian tube is shorter, more floppy, and more horizontally positioned than in adults, permitting nasal secretions to enter the middle ear more easily), physiology, genetic predisposition, and immunologic naiveté; other contributing factors have yet to be defined [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Family history
         </strong>
         – Family history of AOM is a risk factor for AOM, particularly among children who have siblings [
         <a href="#rid6">
          6
         </a>
         ]. In a prospective study of 615 children in the post-PCV era, the risk of AOM was increased in children with siblings and a family history of recurrent AOM (ie, &gt;3 episodes of AOM or tympanostomy tube insertion for persistent/recurrent middle ear fluid in a sibling or either parent; odds ratio [OR] 3.7, 95% CI 2.5-5.8) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The role of genetic factors in the development of AOM is suggested by a two-year prospective study of same-sex twins and triplets [
         <a href="#rid25">
          25
         </a>
         ]. The estimate of discordance for an episode of AOM was greater among dizygotic than monozygotic twins (0.49 versus 0.04 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Potential pathogenetic mechanisms for the heritability of AOM include anatomic, physiologic, and/or immunologic features. Polymorphisms in proinflammatory cytokine genes and genes involved in innate and adaptive immunity that increase susceptibility to otitis media and recurrent AOM have been identified [
         <a href="#rid26">
          26-30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Day care
         </strong>
         – The transmission of bacterial and viral pathogens is common in day care centers. In observational studies from the post-PCV era, day care attendance was associated with an increased risk of AOM, with ORs ranging from 2.8 to 5.0 [
         <a href="#rid6">
          6,31,32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Tobacco smoke and air pollution
         </strong>
         – Exposure to tobacco smoke increases the risk of AOM. In pooled analysis of three studies (1784 children), the risk ratio (RR) of AOM was 1.66 (95% CI 1.33-2.06) among children whose parents/caregivers smoked [
         <a href="#rid33">
          33
         </a>
         ]. In another pooled analysis, the OR for recurrent AOM was 1.48 (95% CI 1.08-2.04) if either parent smoked [
         <a href="#rid34">
          34
         </a>
         ]. The mechanism for this association is not entirely clear but may be related to increased nasopharyngeal and oropharyngeal carriage of otopathogens with exposure to smoke [
         <a href="#rid35">
          35,36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6375.html" rel="external">
          "Secondhand smoke exposure: Effects in children", section on 'Middle ear disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Ambient air pollution also has been associated with increased risk of AOM in observational studies, but the findings are inconsistent for many pollutants [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pacifier use
         </strong>
         – In observational studies from the pre-PCV era, pacifier use was been associated with increased risk of AOM [
         <a href="#rid33">
          33,38
         </a>
         ]. In pooled analysis of two studies (4110 children), children who used a pacifier had a slightly higher incidence of AOM than children who did not (RR 1.24, 95% CI 1.06-1.46) [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Race and ethnicity
         </strong>
         – Native American children, Alaskan and Canadian Inuit children, and indigenous Australian and Greenlander children have a higher incidence of severe and recurrent AOM than do White children [
         <a href="#rid39">
          39,40
         </a>
         ]. In some indigenous Australian populations, 40 percent of the children may have chronic perforation of the tympanic membrane by 18 months of age [
         <a href="#rid41">
          41
         </a>
         ]. In a prospective study, severe otitis media was also more likely to be reported in Bedouin than in Jewish children in Israel; severe otitis media was attributed to crowded living conditions and nasopharyngeal colonization earlier in life among Bedouin children; genetic differences were not investigated [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Limited resources
         </strong>
         – Lack of access to medical care and local environmental factors lead to severe suppurative episodes of otitis media in children living in resource-limited settings [
         <a href="#rid43">
          43
         </a>
         ]. Additional risk factors for chronic suppurative otitis media are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13590.html" rel="external">
          "Chronic suppurative otitis media (CSOM): Clinical features and diagnosis", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other risk factors
         </strong>
         – Other important risk factors in the development of single and recurrent episodes of AOM include [
         <a href="#rid44">
          44
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Season (increased incidence during the fall and winter months, presumably due to respiratory virus activity)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Altered host defenses and underlying disease (eg, human immunodeficiency virus [HIV], cleft palate, Down syndrome, allergic rhinitis)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Protective factors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Breastfeeding
         </strong>
         – Breastfeeding protects against AOM during the first two years of life [
         <a href="#rid6">
          6,31,45-47
         </a>
         ]. Exclusive breastfeeding for at least six months is associated with the greatest protection, but any breastfeeding compared with no breastfeeding also appears to be beneficial. Limited breastfeeding or not having been breastfed is associated with an increased risk of AOM.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In meta-analysis of five observational studies (including&gt;17,700 patients), exclusive breastfeeding from birth to age six months was associated with decreased risk of AOM before age two years (OR 0.57, 95% CI 0.44-0.75) [
         <a href="#rid47">
          47
         </a>
         ]. In meta-analysis of five observational studies (including &gt;19,600 patients), any breastfeeding was associated with decreased risk of AOM before age two years compared with no breastfeeding (OR 0.67, 95% CI 0.56-0.80). Although most of the studies included in these meta-analyses were from the pre-PCV era, studies from the post-PCV era also support the protective effect of breastfeeding.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Breastfeeding diminishes colonization of the nasopharynx by bacterial otopathogens (eg,
         <em>
          Streptococcus pneumoniae
         </em>
         , nontypeable
         <em>
          Haemophilus influenzae
         </em>
         ) [
         <a href="#rid33">
          33,46,48
         </a>
         ]. Additional reasons for the lower incidence of AOM among breastfed infants are uncertain but may be related to immunologic or nonimmune protective factors in breast milk, the facial musculature associated with breastfeeding, or the position maintained during feeding from the breast contrasted with bottle feeding [
         <a href="#rid49">
          49,50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5013.html" rel="external">
          "Infant benefits of breastfeeding", section on 'Biologically active components of human milk'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Xylitol
         </strong>
         – Although daily administration of oral xylitol reduces the risk of AOM, the beneficial effect requires administration three to five times per day, which limits its practicability. The use of xylitol to prevent AOM in children is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5998.html" rel="external">
          "Acute otitis media in children: Prevention of recurrence", section on 'Xylitol'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The middle ear is a narrow chamber that is part of an aerated system that includes the nares, the Eustachian tube, and the mastoid air cells  (
         <a class="graphic graphic_figure graphicRef75010" href="/z/d/graphic/75010.html" rel="external">
          figure 1
         </a>
         ). The system is lined with respiratory mucosa; events affecting one area are usually reflected in similar changes throughout the system. Extension of the suppurative process to adjacent structures may lead to complications such as mastoiditis, labyrinthitis, petrositis, meningitis, and lateral sinus thrombosis. (See
         <a class="local">
          'Complications and sequelae'
         </a>
         below.)
        </p>
        <p>
         The pathogenesis of AOM in at-risk children generally involves the following sequence of events [
         <a href="#rid51">
          51-54
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The patient has an antecedent event (usually a viral upper respiratory tract infection) while colonized with an otopathogen(s) [
         <a href="#rid45">
          45
         </a>
         ]. Some evidence suggests that co-colonization with bacterial otopathogens may be sufficient to trigger the cascade of events in the absence of viral respiratory infection [
         <a href="#rid53">
          53,55,56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The event results in inflammatory edema of the respiratory mucosa of the nose, nasopharynx, and Eustachian tube.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inflammatory edema obstructs the narrowest portion of the Eustachian tube (the isthmus).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstruction of the isthmus causes poor ventilation and negative middle ear pressure. This leads to the accumulation of secretions produced by the middle ear mucosa.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viruses and bacteria that colonize the upper respiratory tract enter the middle ear via aspiration, reflux, or insufflation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microbial growth in the middle ear secretions often progresses to suppuration with clinical signs of AOM (bulging tympanic membrane [TM], middle ear fluid, erythematous TM).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The middle ear effusion may persist for weeks to months following sterilization of the middle ear infection. (See
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment", section on 'Clinical course without antibiotics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The microbiology of AOM has been documented by cultures, viral studies, and molecular studies of middle ear effusion obtained by needle aspiration [
         <a href="#rid57">
          57-59
         </a>
         ]. When a variety of microbiologic methods are used, bacterial and/or viral respiratory tract pathogens can be isolated from most middle ear aspirates from children with AOM [
         <a href="#rid59">
          59-61
         </a>
         ]. In one series of 79 children with AOM and new onset otorrhea through a tympanostomy tube, bacteria (with or without viruses) were detected in 92 percent, viruses (with or without bacteria) in 70 percent, and both bacteria and viruses in 66 percent [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Bacterial pathogens
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          S. pneumoniae
         </em>
         , nontypeable
         <em>
          H. influenzae
         </em>
         (NTHi), and
         <em>
          Moraxella catarrhalis
         </em>
         are the most common bacteria isolated from middle ear fluid in children with AOM [
         <a href="#rid2">
          2,6,12,61-64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3747129729">
         <span class="h3">
          Effect of infant immunization
         </span>
         <span class="headingEndMark">
          —
         </span>
         Universal infant immunization with pneumococcal conjugate vaccines (PCVs) has affected the microbiology of AOM in children by altering the relative importance of the bacterial pathogens most frequently isolated from the middle ear fluid (ie,
         <em>
          S. pneumoniae
         </em>
         ,
         <em>
          H. influenzae
         </em>
         ,
         <em>
          M. catarrhalis
         </em>
         ) as well as the most frequently isolated serotypes of
         <em>
          S. pneumoniae.
         </em>
         These changes affect the choice of antimicrobial therapy when treatment is indicated. (See
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment", section on 'Initial antibiotic therapy'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pre-heptavalent PCV (PCV7)
         </strong>
         – Before the introduction of PCV7  (
         <a class="graphic graphic_table graphicRef77274" href="/z/d/graphic/77274.html" rel="external">
          table 1
         </a>
         ), PCV7 serotypes accounted for 60 to 70 percent of AOM isolates in the 6- to 59-month age group [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Post-PCV7
         </strong>
         –
         <strong>
         </strong>
         In the years immediately following introduction of PCV7, prospective studies in community-based pediatric practices noted declines in the proportion of
         <em>
          S. pneumoniae
         </em>
         isolates from middle ear fluid (from approximately 45 to 30 percent) and increases in the proportion of NTHi isolates (from approximately 40 to 55 percent) [
         <a href="#rid2">
          2,62,66
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although the proportion of NTHi isolates from the middle ear fluid increased, studies of the incidence of NTHi AOM were inconsistent, with some suggesting an increase while others suggested declines in NTHi AOM in early episodes but increased incidence in recurrent disease [
         <a href="#rid2">
          2,64,66-69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Following the introduction of PCV7, most pneumococcal isolates recovered from the middle ear of children with AOM and the nasopharynx of asymptomatic children were non-PCV7 serotypes [
         <a href="#rid64">
          64,66,70-72
         </a>
         ]. Multidrug-resistant serotype 19A was reported as a cause of recalcitrant AOM [
         <a href="#rid70">
          70,72,73
         </a>
         ] and coalescent mastoiditis [
         <a href="#rid74">
          74
         </a>
         ]. Serotype 19A is included in the 13-valent PCV (
         <a class="drug drug_pediatric" data-topicid="15567" href="/z/d/drug information/15567.html" rel="external">
          PCV13
         </a>
         ), which replaced PCV7 in 2010 in the United States, and in the 15-valent PCV (
         <a class="drug drug_pediatric" data-topicid="139114" href="/z/d/drug information/139114.html" rel="external">
          PCV15
         </a>
         ), which became an alternative to PCV13 for children in the United States in 2022 [
         <a href="#rid75">
          75
         </a>
         ]. Serotype 19A is not included in
         <a class="drug drug_pediatric" data-topicid="126388" href="/z/d/drug information/126388.html" rel="external">
          PCV10
         </a>
         , which is used in many countries outside the United States.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Post-PCV13
         </strong>
         – With the introduction of
         <a class="drug drug_pediatric" data-topicid="15567" href="/z/d/drug information/15567.html" rel="external">
          PCV13
         </a>
         in 2010, the proportion of
         <em>
          S. pneumoniae
         </em>
         isolates continues to be lower than reported in the pre-PCV7 era and the proportions of
         <em>
          M. catarrhalis
         </em>
         and NTHi remain increased [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Following the introduction of the
         <a class="drug drug_pediatric" data-topicid="15567" href="/z/d/drug information/15567.html" rel="external">
          PCV13
         </a>
         , studies of tympanocentesis-confirmed AOM in children in the United States and Israel demonstrated declines in overall episodes of AOM and in episodes of AOM due to PCV13 serotypes [
         <a href="#rid12">
          12,76-78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although the study from Israel found no increase in AOM due to non-PCV13 pneumococcal serotypes or NTHi [
         <a href="#rid78">
          78
         </a>
         ], in a prospective study of children with tympanocentesis-confirmed AOM in Rochester, New York,
         <em>
          H. influenzae
         </em>
         was the most commonly isolated pathogen and the majority of
         <em>
          S. pneumoniae
         </em>
         isolates were non-PCV13 serotypes [
         <a href="#rid77">
          77
         </a>
         ]. Among the
         <em>
          S. pneumoniae
         </em>
         isolates, only 9 percent were
         <a class="drug drug_pediatric" data-topicid="15567" href="/z/d/drug information/15567.html" rel="external">
          PCV13
         </a>
         serotypes; 8 percent were serotype 22F or 33F, the two additional serotypes contained in
         <a class="drug drug_pediatric" data-topicid="139114" href="/z/d/drug information/139114.html" rel="external">
          PCV15
         </a>
         , which was licensed for use in children ≥6 weeks of age in 2022 [
         <a href="#rid75">
          75,77
         </a>
         ]. Similarly, in a study from Italy, non-PCV13 serotypes were isolated from the majority of children with pneumococcal AOM with spontaneous perforation [
         <a href="#rid79">
          79
         </a>
         ], although it is unclear if this represents an increase in disease due to non-PCV13 serotypes or only a reduction in disease due to PCV13 serotypes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Surveillance after licensure of
         <a class="drug drug_pediatric" data-topicid="15567" href="/z/d/drug information/15567.html" rel="external">
          PCV13
         </a>
         has also documented a decline in the prevalence of nasopharyngeal colonization with PCV13 serotypes, including 19A, in children with AOM [
         <a href="#rid80">
          80-83
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Post-PCV10
         </strong>
         –
         <strong>
         </strong>
         The
         <a class="drug drug_pediatric" data-topicid="126388" href="/z/d/drug information/126388.html" rel="external">
          10-valent pneumococcal conjugate vaccine
         </a>
         (PCV10) includes the NTHi protein D as one of the conjugate proteins. PCV10 became available in 2010, although it is not licensed in the United States.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Introduction of
         <a class="drug drug_pediatric" data-topicid="126388" href="/z/d/drug information/126388.html" rel="external">
          PCV10
         </a>
         has been associated with decreased episodes of pneumococcal AOM and vaccine serotype AOM. In randomized clinical trials and in post-marketing, the efficacy of PCV10 against the first episode of clinical AOM in children younger than 24 months was 24 percent (95% CI 9-37 percent); the efficacy against moderate clinical AOM was 18 percent, (95% CI -6 to 26 percent) and the efficacy against severe clinical AOM was 33 percent (95% CI -21 to 62 percent) [
         <a href="#rid18">
          18
         </a>
         ]. A statistically significant decrease in episodes of NTHi AOM has not been reproducibly demonstrated.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3858208646">
         <span class="h3">
          Streptococcus pneumoniae
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          S. pneumoniae
         </em>
         is estimated to account for approximately 15 to 25 percent of bacterial isolates from the middle ear fluid of young children with AOM [
         <a href="#rid6">
          6,78,84,85
         </a>
         ].
        </p>
        <p>
         The proportion of pneumococcal isolates resistant to penicillin varies worldwide, but resistance is more likely in children with recurrent and/or persistent AOM and in those recently exposed to antimicrobial agents [
         <a href="#rid51">
          51,64
         </a>
         ]. Studies of antimicrobial susceptibility among nasopharyngeal and middle ear isolates of
         <em>
          S. pneumoniae
         </em>
         identified increasing resistance to penicillin,
         <a class="drug drug_pediatric" data-topicid="12631" href="/z/d/drug information/12631.html" rel="external">
          amoxicillin
         </a>
         , and third-generation cephalosporins among nonvaccine serotypes in 2013 to 2016 compared with 2010 to 2012 [
         <a href="#rid76">
          76
         </a>
         ]. Despite increases in mean inhibitory concentration for amoxicillin, most isolates of
         <em>
          S. pneumoniae
         </em>
         remain susceptible, using pharmacodynamic breakpoints for high doses (90 mg/kg per day).
        </p>
        <p>
         <em>
          S. pneumoniae
         </em>
         frequently causes first or early otitis media episodes, although
         <em>
          H. influenzae
         </em>
         and
         <em>
          M. catarrhalis
         </em>
         may cause early disease as well [
         <a href="#rid7">
          7,86-88
         </a>
         ].
         <em>
          S. pneumoniae
         </em>
         is isolated with equal frequency in bilateral and unilateral AOM [
         <a href="#rid89">
          89,90
         </a>
         ].
        </p>
        <p>
         <em>
          S. pneumoniae
         </em>
         is associated with greater clinical severity than other otopathogens, as reflected by higher fever, more intense otalgia, and the potential for complications such as bacteremia and mastoiditis [
         <a href="#rid91">
          91
         </a>
         ]. It is also associated with a greater inflammatory response with elevated peripheral blood and middle ear fluid white blood cell counts compared with other pathogens [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1503549052">
         <span class="h3">
          Haemophilus influenzae
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          H. influenzae
         </em>
         is estimated to account for approximately 50 to 60 percent of bacterial isolates from the middle ear fluid of young children with AOM [
         <a href="#rid6">
          6,78,84,85
         </a>
         ].
        </p>
        <p>
         Most
         <em>
          H. influenzae
         </em>
         isolates from the middle ear are NTHi [
         <a href="#rid7">
          7,92
         </a>
         ]. In some settings, NTHi has become the most common bacteria isolated from children with AOM [
         <a href="#rid93">
          93,94
         </a>
         ].
        </p>
        <p>
         The patterns of
         <em>
          H. influenzae
         </em>
         resistance vary geographically, reflecting the dominant antimicrobial agent used in treatment of AOM. Approximately one-third to one-half of strains of
         <em>
          H. influenzae
         </em>
         recovered from middle ear fluids from children in the United States produce beta-lactamase [
         <a href="#rid51">
          51,63,95
         </a>
         ]. In other parts of the world, resistance to
         <a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">
          ampicillin
         </a>
         and cephalosporins may be associated with mutations in the penicillin binding proteins (beta-lactamase negative, ampicillin-resistance) [
         <a href="#rid72">
          72,96-98
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8048.html" rel="external">
          "Epidemiology, clinical manifestations, diagnosis, and treatment of
          <i>
           Haemophilus influenzae
          </i>
          ", section on 'Ampicillin resistance'
         </a>
         .)
        </p>
        <p>
         <em>
          H. influenzae
         </em>
         AOM is more commonly isolated in bilateral than unilateral AOM [
         <a href="#rid89">
          89,90,99
         </a>
         ]. Otitis media caused by NTHi is frequently associated with concurrent conjunctivitis and milder symptoms (eg, lower fever, less inflamed tympanic membrane [TM]) than pneumococcal AOM [
         <a href="#rid86">
          86,90
         </a>
         ]. NTHi infection is also associated with more complex otitis media, including increased risk for treatment failure, recurrence despite appropriate antibiotic therapy, and chronicity [
         <a href="#rid59">
          59,99
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H744774283">
         <span class="h3">
          Moraxella catarrhalis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. catarrhalis
         </em>
         accounts for approximately 12 to 15 percent of bacterial middle ear isolates in children with AOM [
         <a href="#rid6">
          6,78,84,85
         </a>
         ]. It is isolated more commonly in middle ear aspirates or otorrhea specimens in countries where children have been immunized with PCV. Virtually all strains produce beta-lactamase [
         <a href="#rid6">
          6,66
         </a>
         ].
         <em>
          M. catarrhalis
         </em>
         AOM typically is less severe than pneumococcal AOM.
        </p>
        <p class="headingAnchor" id="H2810052719">
         <span class="h3">
          Group A Streptococcus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Group A
         <em>
          Streptococcus
         </em>
         (GAS) occasionally causes AOM (2 to 10 percent of isolates) [
         <a href="#rid2">
          2
         </a>
         ]. GAS AOM tends to occur in older children and to be more frequently associated with local complications (eg, TM perforation, mastoiditis) and less frequently associated with fever and systemic or respiratory symptoms than AOM caused by other organisms [
         <a href="#rid100">
          100-102
         </a>
         ]. (See
         <a class="local">
          'Tympanic membrane abnormalities'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H836269881">
         <span class="h3">
          Staphylococcus aureus
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          S. aureus
         </em>
         is an uncommon cause of AOM, but its prevalence appears to have increased after introduction of PCV7, particularly in children with spontaneous perforation of the tympanic membrane [
         <a href="#rid2">
          2,68,103-105
         </a>
         ]. It is also often found isolated from acute otorrhea in children with tympanostomy tubes in place. Whether isolation of
         <em>
          S. aureus
         </em>
         from discharge in the external canal reflects pathogenicity or commensal bacteria is uncertain. (See
         <a class="medical medical_review" href="/z/d/html/6295.html" rel="external">
          "Tympanostomy tube otorrhea in children: Causes, prevention, and management", section on 'Pathogens'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1560366370">
         <span class="h3">
          Other bacteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria infrequently cause AOM. Enteric gram-negative bacilli such as
         <em>
          Escherichia coli
         </em>
         may cause AOM in the first months of life [
         <a href="#rid106">
          106,107
         </a>
         ].
         <em>
          Pseudomonas aeruginosa
         </em>
         has a special role in chronic suppurative otitis media. (See
         <a class="medical medical_review" href="/z/d/html/3148.html" rel="external">
          "Pseudomonas aeruginosa infections of the eye, ear, urinary tract, gastrointestinal tract, and central nervous system", section on 'Ear infections'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Viral pathogens
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microbiologic and epidemiologic data suggest that viral infection is frequently associated with AOM [
         <a href="#rid60">
          60,108-111
         </a>
         ]. With advances in microbiologic techniques, including reverse transcriptase polymerase chain reaction, viruses are increasingly detected in the middle ear fluid of children with AOM [
         <a href="#rid60">
          60,110
         </a>
         ]. The most frequently isolated viruses are respiratory syncytial virus (RSV), picornaviruses (eg, rhinovirus, enterovirus), coronaviruses, influenza viruses, adenoviruses, and human metapneumovirus. However, in an epidemiologic study, only influenza, RSV, and human metapneumovirus activity in the community were associated with an increase in AOM diagnoses [
         <a href="#rid112">
          112
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Other pathogens
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Mycoplasma pneumoniae
         </em>
         rarely has been isolated from middle ear fluids of children with AOM. (See
         <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in children", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Chlamydia trachomatis
         </em>
         has been associated with otitis media in infants younger than six months of age. (See
         <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">
          "Chlamydia trachomatis infections in the newborn"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Chlamydia pneumoniae
         </em>
         has been isolated from some patients with acute and chronic otitis media [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3911554921">
         <span class="h2">
          Dual pathogen infection
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dual bacterial infections
         </strong>
         – Dual bacterial infection, most commonly involving
         <em>
          S. pneumoniae
         </em>
         and
         <em>
          H. influenzae
         </em>
         , has been identified in children with persistent AOM and/or recurrent otitis media from multiple countries [
         <a href="#rid42">
          42,113-115
         </a>
         ]. The persistence and recurrence of polymicrobial otitis media probably reflects biofilms in the middle ear space. In a prospective study, dual bacterial infection with
         <em>
          S. pneumoniae
         </em>
         and
         <em>
          H. influenzae
         </em>
         was more likely in children living in crowded living conditions with early colonization; nonvaccine serotypes were involved most frequently [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bacterial and viral infections
         </strong>
         –
         <strong>
         </strong>
         Bacterial and viral coinfection is common in children with recurrent AOM. In one series of 79 children with AOM and new onset otorrhea through a tympanostomy tube, both bacteria and viruses were isolated in 66 percent [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The frequency of mixed bacterial and viral infections has important clinical implications [
         <a href="#rid116">
          116
         </a>
         ]. Mixed bacterial and viral infections may respond differently to antibiotic therapy than purely bacterial infections [
         <a href="#rid117">
          117,118
         </a>
         ]. The presence of viruses may increase middle ear inflammation [
         <a href="#rid119">
          119,120
         </a>
         ], decrease neutrophil function [
         <a href="#rid121">
          121
         </a>
         ], and reduce antibiotic penetration into the middle ear [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2264029864">
         <span class="h1">
          PATHOGENS IN SPECIAL POPULATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H164880855">
         <span class="h2">
          Young infants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial pathogens isolated from the middle ear aspirates of young infants with AOM typically are similar to those identified in older children (eg,
         <em>
          S. pneumoniae
         </em>
         and
         <em>
          H. influenzae
         </em>
         ). In infants younger than two weeks, pathogens that cause neonatal sepsis (group B
         <em>
          Streptococcus
         </em>
         , enteric gram-negative bacilli, and
         <em>
          S. aureus
         </em>
         ) also may be found. (See
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Etiologic agents'
         </a>
         .)
        </p>
        <p>
         Few studies have evaluated the microbiology of AOM in young infants after the introduction of pneumococcal conjugate vaccine (PCV). In an observational study of 182 infants &lt;2 months of age from Israel who underwent tympanocentesis before (2005 to 2009) and after (2010 to 2014) the introduction of PCV, the proportion of
         <em>
          S. pneumoniae
         </em>
         and
         <em>
          H. influenzae
         </em>
         isolates decreased after the introduction of PCV (from 50 to 30 percent and 30 to 23 percent, respectively) and the proportion of culture-negative patients increased (from 19.6 to 35.6 percent) [
         <a href="#rid123">
          123
         </a>
         ]. Among the 23 infants (13 percent) with concomitant serious bacterial infection, 19 had urinary tract infections which were generally caused by pathogens different than those isolated from middle ear fluid.
        </p>
        <p class="headingAnchor" id="H164315075">
         <span class="h2">
          Resource-limited countries
         </span>
         <span class="headingEndMark">
          —
         </span>
         In resource-limited countries, the most common bacterial causes of AOM are the same as in developed countries [
         <a href="#rid124">
          124-126
         </a>
         ].
        </p>
        <p>
         In addition, otitis media may be caused by
         <em>
          Mycobacteria tuberculosis
         </em>
         ,
         <em>
          Corynebacterium diphtheriae
         </em>
         , and
         <em>
          Clostridium tetani
         </em>
         . Parasitic (
         <em>
          Ascaris lumbricoides
         </em>
         ) and fungal (
         <em>
          Blastomyces dermatitidis
         </em>
         ,
         <em>
          Candida
         </em>
         and
         <em>
          Aspergillus
         </em>
         species) middle ear infections may occur but are rare [
         <a href="#rid124">
          124
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          COMPLICATIONS AND SEQUELAE
         </span>
        </p>
        <p class="headingAnchor" id="H111860507">
         <span class="h2">
          Intratemporal complications
         </span>
        </p>
        <p class="headingAnchor" id="H22228262">
         <span class="h3">
          Hearing loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients with middle ear effusion have persistent or fluctuating conductive hearing loss. Fluid filling the middle ear space prevents the tympanic membrane (TM) from vibrating adequately, thereby diminishing movement of the ossicular chain. The hearing loss remains as long as fluid fills the middle ear space. The median hearing threshold is 25 dB, which is equivalent to putting plugs in the child's ears [
         <a href="#rid127">
          127
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6308.html" rel="external">
          "Hearing loss in children: Etiology", section on 'Infection'
         </a>
         .)
        </p>
        <p>
         Despite treatment with appropriate antimicrobial agents, middle ear fluid may persist for weeks to months after the onset of signs of AOM. (See
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment", section on 'Clinical course without antibiotics'
         </a>
         .)
        </p>
        <p>
         Consequences and sequelae of prolonged middle ear effusion are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5966.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Clinical features and diagnosis", section on 'Hearing loss'
         </a>
         .)
        </p>
        <p>
         Sensorineural hearing loss is an uncommon consequence of AOM but may occur.
        </p>
        <p class="headingAnchor" id="H104578870">
         <span class="h3">
          Balance and motor problems
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with AOM may have balance, motor, or vestibular problems related to vestibular dysfunction or labyrinthitis [
         <a href="#rid128">
          128-132
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">
          "Causes of vertigo", section on 'Otitis media'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h3">
          Tympanic membrane abnormalities
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perforation
         </strong>
         – The increased pressure in the middle ear can result in central ischemia, necrosis, and spontaneous perforation of the TM, usually accompanied by otorrhea  (
         <a class="graphic graphic_picture graphicRef97987" href="/z/d/graphic/97987.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid133">
          133
         </a>
         ]. The risk of perforation is increased in children initially observed without antimicrobial therapy and in children with dual pathogen infections, including nontypeable
         <em>
          H. influenzae
         </em>
         and
         <em>
          M. catarrhalis
         </em>
         [
         <a href="#rid102">
          102,134,135
         </a>
         ]. (See
         <a class="local">
          'Group A Streptococcus'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The frequency of spontaneous perforation is increased in Native American and Australian Aborigine children and in children in resource-limited countries [
         <a href="#rid39">
          39
         </a>
         ]. AOM caused by group A
         <em>
          Streptococcus
         </em>
         is associated with higher rates of TM perforation than AOM caused by other pathogens [
         <a href="#rid100">
          100-102
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The treatment of TM perforation associated with AOM is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment", section on 'Tympanic membrane perforation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Myringosclerosis
         </strong>
         –
         <strong>
         </strong>
         Myringosclerosis (calcification of the connective tissue of TM, sometimes called tympanosclerosis) is a complication of frequent middle ear disease [
         <a href="#rid136">
          136
         </a>
         ]. It is characterized by whitish plaques in the TM  (
         <a class="graphic graphic_picture graphicRef58460 graphicRef78073" href="/z/d/graphic/58460.html" rel="external">
          picture 4A-B
         </a>
         ) and occasionally the middle ear. In most children, myringosclerosis is of no functional importance, but in some, the deposits may envelop the ossicles, resulting in a conductive hearing loss.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Retraction or collapse
         </strong>
         –
         <strong>
         </strong>
         Chronic or recurrent decreased pressure in the middle ear in children with recurrent AOM may lead to retraction (atelectasis) or collapse of the TM (middle ear atelectasis)  (
         <a class="graphic graphic_picture graphicRef78843" href="/z/d/graphic/78843.html" rel="external">
          picture 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H111861298">
         <span class="h3">
          Chronic suppurative otitis media
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unresolved or complicated AOM with perforation of the TM may lead to chronic suppurative otitis media (CSOM) or chronic otomastoiditis, which is defined as perforation of the TM with chronic purulent drainage from the middle ear cleft for more than six weeks  (
         <a class="graphic graphic_picture graphicRef91415" href="/z/d/graphic/91415.html" rel="external">
          picture 6
         </a>
         ). Most often CSOM is the end stage of recurrent AOM episodes that begin in the first year of life. (See
         <a class="medical medical_review" href="/z/d/html/13590.html" rel="external">
          "Chronic suppurative otitis media (CSOM): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
         Children with TM perforation and suppurative discharge that persists despite oral and/or topical antibiotics should be referred to an infectious disease specialist or otolaryngologist as soon as possible and a sample for a bacterial culture should be obtained to ensure optimal antimicrobial treatment. Children with perforation without drainage that persists for three months or longer should be referred to an otolaryngologist for further management [
         <a href="#rid133">
          133
         </a>
         ]. Prevention of CSOM entails prompt and appropriate treatment of acute middle ear infection [
         <a href="#rid39">
          39
         </a>
         ]. Chemoprophylaxis is not warranted. (See
         <a class="medical medical_review" href="/z/d/html/91002.html" rel="external">
          "Chronic suppurative otitis media (CSOM): Treatment, complications, and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111859946">
         <span class="h3">
          Cholesteatoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         A cholesteatoma is an abnormal growth of squamous epithelium in the middle ear and mastoid that may progressively enlarge to surround and destroy the ossicles. Recurrent AOM, which may lead to retraction pockets in the TM, is a risk factor for cholesteatoma.
        </p>
        <p>
         Clinical features suggestive of acquired cholesteatomas include deep retraction pockets, as in panel A of the picture  (
         <a class="graphic graphic_picture graphicRef54514" href="/z/d/graphic/54514.html" rel="external">
          picture 7
         </a>
         ), a white mass behind the TM  (
         <a class="graphic graphic_picture graphicRef76079" href="/z/d/graphic/76079.html" rel="external">
          picture 8
         </a>
         ), focal granulation at the periphery of the TM  (
         <a class="graphic graphic_picture graphicRef72182" href="/z/d/graphic/72182.html" rel="external">
          picture 9
         </a>
         ), new-onset hearing loss, and ear drainage for more than two weeks despite treatment. The diagnosis and management of cholesteatoma are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6306.html" rel="external">
          "Cholesteatoma in children", section on 'Clinical features'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6306.html" rel="external">
          "Cholesteatoma in children", section on 'Surgical treatment'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h3">
          Mastoiditis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most episodes of AOM are associated with some inflammation of the mastoid because the mastoid air cells are connected to the distal end of the middle ear through a small canal or antrum  (
         <a class="graphic graphic_figure graphicRef74487" href="/z/d/graphic/74487.html" rel="external">
          figure 2
         </a>
         ). In rare cases, resolution of the mastoid infection does not occur, and acute suppurative mastoiditis develops with pus filling the air cells.
        </p>
        <p>
         The pathogenesis, epidemiology, and clinical features of mastoiditis in children are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111860927">
         <span class="h3">
          Other intratemporal complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other intratemporal complications of AOM include [
         <a href="#rid128">
          128
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Petrositis (extension of the infection into the petrous portion of the mastoid bone) (see
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Complications'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Labyrinthitis (extension of infection into the cochlear and vestibular apparatus) (see
         <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">
          "Causes of vertigo", section on 'Otitis media'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Facial paralysis (the facial nerve courses through the middle ear and mastoid); facial paralysis also may occur as a complication of acute mastoiditis or CSOM (see
         <a class="medical medical_review" href="/z/d/html/6217.html" rel="external">
          "Facial nerve palsy in children", section on 'Otitis media'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h2">
          Intracranial complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intracranial complications of AOM are uncommon in resource-rich countries. However, they remain a concern in resource-limited countries where there is poor access to medical care [
         <a href="#rid124">
          124,137
         </a>
         ]. Intracranial complications of AOM include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meningitis (see
         <a class="medical medical_review" href="/z/d/html/5968.html" rel="external">
          "Bacterial meningitis in children older than one month: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidural abscess (see
         <a class="medical medical_review" href="/z/d/html/103898.html" rel="external">
          "Intracranial epidural abscess", section on 'Clinical manifestations'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brain abscess (see
         <a class="medical medical_review" href="/z/d/html/1297.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of brain abscess", section on 'Clinical manifestations'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lateral sinus thrombosis (see
         <a class="medical medical_review" href="/z/d/html/3410.html" rel="external">
          "Septic dural sinus thrombosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cavernous sinus thrombosis (see
         <a class="medical medical_review" href="/z/d/html/3410.html" rel="external">
          "Septic dural sinus thrombosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subdural empyema (collection of purulent material between the dura and the arachnoid membrane)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Carotid artery thrombosis
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13825938">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/15373.html" rel="external">
          "Patient education: Ear infections in children (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topic (see
         <a class="medical medical_patient" href="/z/d/html/1204.html" rel="external">
          "Patient education: Ear infections (otitis media) in children (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H34">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Acute otitis media (AOM) is defined by moderate to severe bulging  (
         <a class="graphic graphic_picture graphicRef63268" href="/z/d/graphic/63268.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef127414" href="/z/d/graphic/127414.html" rel="external">
          picture 2
         </a>
         ) of the tympanic membrane or new onset of otorrhea not due to acute otitis externa accompanied by acute signs of illness and signs or symptoms of middle ear inflammation. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology and risk factors
         </strong>
         – AOM occurs at all ages but is most prevalent between 6 and 24 months of age, after which it begins to decline. The incidence of AOM declined following the introduction of pneumococcal conjugate vaccines. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Viral upper respiratory infection is the most common predisposing factor for the development of AOM. The incidence of AOM in the United States is highest between 6 and 12 months of age and during the respiratory virus season. In addition to young age, risk factors for AOM include family history, day care attendance, exposure to tobacco smoke, and pacifier use. The risk of severe and recurrent AOM is increased among Native American children, Alaskan and Canadian Inuit children, and indigenous Australian and Greenlander children. Breastfeeding is protective. (See
         <a class="local">
          'Risk and protective factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         – Inflammation of the upper respiratory tract predisposes to AOM via dysfunction of the Eustachian tube, leading to negative pressure and accumulation of middle ear secretions and impairment in host defenses (eg, normal mucociliary action). Microbial growth in the middle ear secretions may result in suppuration and clinical signs of AOM. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         –
         <em>
          Streptococcus pneumoniae
         </em>
         , nontypeable
         <em>
          Haemophilus influenzae
         </em>
         (NTHi), and
         <em>
          Moraxella catarrhalis
         </em>
         account for most of the bacterial isolates from middle ear fluid. The most common viral pathogens include respiratory syncytial virus, picornaviruses (eg, rhinoviruses, enterovirus), coronaviruses, influenza viruses, adenoviruses, and human metapneumovirus. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In young infants (ie, &lt;2 months of age), the most common bacterial causes of AOM are the same as they are in older children (eg,
         <em>
          S. pneumoniae
         </em>
         and
         <em>
          H. influenzae
         </em>
         ); in those &lt;2 weeks of age, AOM also may be caused by group B
         <em>
          Streptococcus
         </em>
         , enteric gram-negative bacilli, and
         <em>
          S. aureus
         </em>
         . (See
         <a class="local">
          'Young infants'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In resource-limited countries, the most common bacterial causes of AOM are the same as in developed countries. Additional bacterial pathogens include
         <em>
          Mycobacteria tuberculosis
         </em>
         ,
         <em>
          Corynebacterium diphtheriae
         </em>
         , and
         <em>
          Clostridium tetani
         </em>
         . (See
         <a class="local">
          'Resource-limited countries'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications and sequelae
         </strong>
         – Intratemporal complications of AOM include mild conductive hearing loss; vestibular, balance, and motor dysfunctions; TM perforation; inflammation of the mastoid and/or suppurative mastoiditis; petrositis; and labyrinthitis. Intracranial complications are rare in resource-abundant countries but more frequent in resource-limited countries; they include meningitis, epidural abscess, brain abscess, lateral sinus thrombosis, cavernous sinus thrombosis, subdural empyema, and carotid artery thrombosis. (See
         <a class="local">
          'Complications and sequelae'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2092888055">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate would like to acknowledge Jerome Klein, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics 2013; 131:e964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 2010; 304:2161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marom T, Tan A, Wilkinson GS, et al. Trends in otitis media-related health care use in the United States, 2001-2011. JAMA Pediatr 2014; 168:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tong S, Amand C, Kieffer A, Kyaw MH. Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008-2014. BMC Health Serv Res 2018; 18:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989; 160:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaur R, Morris M, Pichichero ME. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era. Pediatrics 2017; 140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Dyke MK, Pirçon JY, Cohen R, et al. Etiology of Acute Otitis Media in Children Less Than 5 Years of Age: A Pooled Analysis of 10 Similarly Designed Observational Studies. Pediatr Infect Dis J 2017; 36:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Todberg T, Koch A, Andersson M, et al. Incidence of otitis media in a contemporary Danish National Birth Cohort. PLoS One 2014; 9:e111732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poehling KA, Lafleur BJ, Szilagyi PG, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics 2004; 114:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pichichero M, Kaur R, Scott DA, et al. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study. Lancet Child Adolesc Health 2018; 2:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawai K, Adil EA, Barrett D, et al. Ambulatory Visits for Otitis Media before and after the Introduction of Pneumococcal Conjugate Vaccination. J Pediatr 2018; 201:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pichichero ME. Ten-Year Study of Acute Otitis Media in Rochester, NY. Pediatr Infect Dis J 2016; 35:1027.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiese AD, Huang X, Yu C, et al. Changes in Otitis Media Episodes and Pressure Equalization Tube Insertions Among Young Children Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Birth Cohort-based Study. Clin Infect Dis 2019; 69:2162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113:1451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lau WC, Murray M, El-Turki A, et al. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine 2015; 33:5072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenblut A, Rosenblut M, García K, et al. Frequency of Acute Otitis Media in Children Under 24 Months of Age Before and After the Introduction of the 10-valent Pneumococcal Conjugate Vaccine Into the National Immunization Program in Chile. Pediatr Infect Dis J 2018; 37:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gisselsson-Solen M. Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination: A National Observational Study. Pediatr Infect Dis J 2017; 36:1027.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sáez-Llorens X, Rowley S, Wong D, et al. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial. Hum Vaccin Immunother 2017; 13:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigurdsson S, Eythorsson E, Hrafnkelsson B, et al. Reduction in All-Cause Acute Otitis Media in Children &lt;3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study. Clin Infect Dis 2018; 67:1213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angoulvant F, Ouldali N, Yang DD, et al. Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis. Clin Infect Dis 2021; 72:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuitunen I, Artama M, Mäkelä L, et al. Effect of Social Distancing Due to the COVID-19 Pandemic on the Incidence of Viral Respiratory Tract Infections in Children in Finland During Early 2020. Pediatr Infect Dis J 2020; 39:e423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zloczower E, Pitaro J, Hazan I, et al. Fluctuations in Pediatric Acute Otitis Media Burden During the First Two COVID-19 Years in Israel. Pediatr Infect Dis J 2023; 42:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ishijima K, Sando I, Balaban C, et al. Length of the eustachian tube and its postnatal development: computer-aided three-dimensional reconstruction and measurement study. Ann Otol Rhinol Laryngol 2000; 109:542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pagano AS, Wang E, Yuan D, et al. Cranial Indicators Identified for Peak Incidence of Otitis Media. Anat Rec (Hoboken) 2017; 300:1721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casselbrant ML, Mandel EM, Fall PA, et al. The heritability of otitis media: a twin and triplet study. JAMA 1999; 282:2125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel JA, Nair S, Revai K, et al. Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media. Pediatrics 2006; 118:2273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Emonts M, Wiertsema SP, Veenhoven RH, et al. The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media. Pediatrics 2007; 120:e317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 2007; 120:814.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nokso-Koivisto J, Chonmaitree T, Jennings K, et al. Polymorphisms of immunity genes and susceptibility to otitis media in children. PLoS One 2014; 9:e93930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toivonen L, Vuononvirta J, Mertsola J, et al. Polymorphisms of Mannose-binding Lectin and Toll-like Receptors 2, 3, 4, 7 and 8 and the Risk of Respiratory Infections and Acute Otitis Media in Children. Pediatr Infect Dis J 2017; 36:e114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ladomenou F, Kafatos A, Tselentis Y, Galanakis E. Predisposing factors for acute otitis media in infancy. J Infect 2010; 61:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prins-van Ginkel AC, Bruijning-Verhagen PC, Uiterwaal CS, et al. Acute Otitis Media During Infancy: Parent-reported Incidence and Modifiable Risk Factors. Pediatr Infect Dis J 2017; 36:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uhari M, Mäntysaari K, Niemelä M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis 1996; 22:1079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strachan DP, Cook DG. Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children. Thorax 1998; 53:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg D, Givon-Lavi N, Broides A, et al. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis 2006; 42:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy TF. Otitis media, bacterial colonization, and the smoking parent. Clin Infect Dis 2006; 42:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowatte G, Tham R, Perret JL, et al. Air Pollution and Otitis Media in Children: A Systematic Review of Literature. Int J Environ Res Public Health 2018; 15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rovers MM, Numans ME, Langenbach E, et al. Is pacifier use a risk factor for acute otitis media? A dynamic cohort study. Fam Pract 2008; 25:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bluestone CD. Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment. Int J Pediatr Otorhinolaryngol 1998; 42:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leach AJ, Wigger C, Andrews R, et al. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC Pediatr 2014; 14:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris PS, Leach AJ, Silberberg P, et al. Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey. BMC Pediatr 2005; 5:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dagan R, Leibovitz E, Greenberg D, et al. Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution. J Infect Dis 2013; 208:1152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minja BM, Machemba A. Prevalence of otitis media, hearing impairment and cerumen impaction among school children in rural and urban Dar es Salaam, Tanzania. Int J Pediatr Otorhinolaryngol 1996; 37:29.
          </a>
         </li>
         <li class="breakAll">
          Bluestone CD, Klein JO. Epidemiology. In: Otitis media in infants and children, 4th ed, BC Decker, Hamilton, ON 2007. p.73.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chonmaitree T, Trujillo R, Jennings K, et al. Acute Otitis Media and Other Complications of Viral Respiratory Infection. Pediatrics 2016; 137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ip S, Chung M, Raman G, et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) 2007; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowatte G, Tham R, Allen KJ, et al. Breastfeeding and childhood acute otitis media: a systematic review and meta-analysis. Acta Paediatr 2015; 104:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biesbroek G, Bosch AA, Wang X, et al. The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am J Respir Crit Care Med 2014; 190:298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paradise JL, Elster BA, Tan L. Evidence in infants with cleft palate that breast milk protects against otitis media. Pediatrics 1994; 94:853.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sabirov A, Casey JR, Murphy TF, Pichichero ME. Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6. Pediatr Res 2009; 66:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet 2004; 363:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winther B, Alper CM, Mandel EM, et al. Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season. Pediatrics 2007; 119:1069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Revai K, Mamidi D, Chonmaitree T. Association of nasopharyngeal bacterial colonization during upper respiratory tract infection and the development of acute otitis media. Clin Infect Dis 2008; 46:e34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alper CM, Winther B, Mandel EM, et al. Rate of concurrent otitis media in upper respiratory tract infections with specific viruses. Arch Otolaryngol Head Neck Surg 2009; 135:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lysenko ES, Ratner AJ, Nelson AL, Weiser JN. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog 2005; 1:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leach AJ, Boswell JB, Asche V, et al. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J 1994; 13:983.
          </a>
         </li>
         <li class="breakAll">
          Bluestone CD, Klein JO. Microbiology. In: Otitis Media in Infants and Children, 4th ed, BC Decker, Hamilton, ON 2007. p.101.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pichichero ME. Ten-Year Study of the Stringently Defined Otitis-prone Child in Rochester, NY. Pediatr Infect Dis J 2016; 35:1033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ngo CC, Massa HM, Thornton RB, Cripps AW. Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review. PLoS One 2016; 11:e0150949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis 2006; 43:1417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaur R, Adlowitz DG, Casey JR, et al. Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media. Pediatr Infect Dis J 2010; 29:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pichichero ME, Casey JR, Hoberman A, Schwartz R. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr (Phila) 2008; 47:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2010; 29:304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hausdorff WP, Yothers G, Dagan R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002; 21:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23:829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brook I, Gober AE. Bacteriology of spontaneously draining acute otitis media in children before and after the introduction of pneumococcal vaccination. Pediatr Infect Dis J 2009; 28:640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dagan R, Pelton S, Bakaletz L, Cohen R. Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis 2016; 16:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007; 298:1772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McEllistrem MC, Adams JM, Patel K, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2005; 40:1738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Couloigner V, Levy C, François M, et al. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels. Pediatr Infect Dis J 2012; 31:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xu Q, Pichichero ME, Casey JR, Zeng M. Novel type of Streptococcus pneumoniae causing multidrug-resistant acute otitis media in children. Emerg Infect Dis 2009; 15:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ongkasuwan J, Valdez TA, Hulten KG, et al. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics 2008; 122:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 2022; 71:1174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaur R, Pham M, Yu KOA, Pichichero ME. Rising Pneumococcal Antibiotic Resistance in the Post-13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates From a Primary Care Setting. Clin Infect Dis 2021; 72:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaur R, Fuji N, Pichichero ME. Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015-2019. Eur J Clin Microbiol Infect Dis 2022; 41:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ben-Shimol S, Givon-Lavi N, Leibovitz E, et al. Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media. Clin Infect Dis 2016; 63:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchisio P, Esposito S, Picca M, et al. Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage. Pediatr Infect Dis J 2017; 36:521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen R, Levy C, Bingen E, et al. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J 2012; 31:297.
          </a>
         </li>
         <li class="breakAll">
          Pelton SI, et al. Presentation at IDWeek, 2012, San Diego, CA.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin JM, Hoberman A, Paradise JL, et al. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 2014; 33:e286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allemann A, Frey PM, Brugger SD, Hilty M. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland. Vaccine 2017; 35:1946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen R, Varon E, Doit C, et al. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation. Vaccine 2015; 33:5118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wald ER, DeMuri GP. Antibiotic Recommendations for Acute Otitis Media and Acute Bacterial Sinusitis: Conundrum No More. Pediatr Infect Dis J 2018; 37:1255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palmu AA, Herva E, Savolainen H, et al. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 2004; 38:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kilpi T, Herva E, Kaijalainen T, et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001; 20:654.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palmu AA, Lahdenkari M. Early Vaccine-type Pneumococcal Acute Otitis Media Does not Predispose to Subsequent Otitis When Compared With Early Acute Otitis Media Due to Other Bacterial Etiology. Pediatr Infect Dis J 2018; 37:592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCormick DP, Chandler SM, Chonmaitree T. Laterality of acute otitis media: different clinical and microbiologic characteristics. Pediatr Infect Dis J 2007; 26:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leibovitz E, Asher E, Piglansky L, et al. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr Infect Dis J 2007; 26:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodriguez WJ, Schwartz RH. Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis. Pediatr Infect Dis J 1999; 18:942.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuji N, Pichichero M, Kaur R. Haemophilus influenzae Prevalence, Proportion of Capsulated Strains and Antibiotic Susceptibility During Colonization and Acute Otitis Media in Children, 2019-2020. Pediatr Infect Dis J 2021; 40:792.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills N, Best EJ, Murdoch D, et al. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination. J Paediatr Child Health 2015; 51:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein A, Tamir SO, Sorek N, et al. Increase in Haemophilus influenzae Detection in 13-Valent Pneumococcal Conjugate Vaccine Immunized Children With Acute Otitis Media. Pediatr Infect Dis J 2022; 41:678.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11:S7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adachi Y, Ando M, Morozumi M, et al. Genotypic characterization of Haemophilus influenzae isolates from paediatric patients in Japan. J Med Microbiol 2018; 67:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Otsuka T, Kitami O, Kondo K, et al. Incidence survey of acute otitis media in children in Sado Island, Japan--Sado Otitis Media Study (SADOMS). PLoS One 2013; 8:e68711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angoulvant F, Cohen R, Doit C, et al. Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction. BMC Infect Dis 2015; 15:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J 2009; 28:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Segal N, Givon-Lavi N, Leibovitz E, et al. Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis 2005; 41:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leibovitz E, Serebro M, Givon-Lavi N, et al. Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media. Pediatr Infect Dis J 2009; 28:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Principi N, Marchisio P, Rosazza C, et al. Acute otitis media with spontaneous tympanic membrane perforation. Eur J Clin Microbiol Infect Dis 2017; 36:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein J, Chan S. Methicillin-resistant Staphylococcus aureus in middle ear fluid of children. Clin Pediatr (Phila) 2010; 49:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003; 361:2189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hullegie S, Venekamp RP, van Dongen TMA, et al. Prevalence and Antimicrobial Resistance of Bacteria in Children With Acute Otitis Media and Ear Discharge: A Systematic Review. Pediatr Infect Dis J 2021; 40:756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner D, Leibovitz E, Aran A, et al. Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J 2002; 21:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nozicka CA, Hanly JG, Beste DJ, et al. Otitis media in infants aged 0-8 weeks: frequency of associated serious bacterial disease. Pediatr Emerg Care 1999; 15:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999; 340:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruuskanen O, Arola M, Heikkinen T, Ziegler T. Viruses in acute otitis media: increasing evidence for clinical significance. Pediatr Infect Dis J 1991; 10:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pitkäranta A, Virolainen A, Jero J, et al. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 1998; 102:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:1369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stockmann C, Ampofo K, Hersh AL, et al. Seasonality of acute otitis media and the role of respiratory viral activity in children. Pediatr Infect Dis J 2013; 32:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alonso M, Marimon JM, Ercibengoa M, et al. Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain. PLoS One 2013; 8:e54333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García-Cobos S, Moscoso M, Pumarola F, et al. Frequent carriage of resistance mechanisms to β-lactams and biofilm formation in Haemophilus influenzae causing treatment failure and recurrent otitis media in young children. J Antimicrob Chemother 2014; 69:2394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thornton RB, Rigby PJ, Wiertsema SP, et al. Multi-species bacterial biofilm and intracellular infection in otitis media. BMC Pediatr 2011; 11:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chonmaitree T. Acute otitis media is not a pure bacterial disease. Clin Infect Dis 2006; 43:1423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chonmaitree T, Owen MJ, Patel JA, et al. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr 1992; 120:856.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chonmaitree T, Owen MJ, Howie VM. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis 1990; 162:546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chonmaitree T, Patel JA, Lett-Brown MA, et al. Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis 1994; 169:1265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chonmaitree T, Patel JA, Sim T, et al. Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol 1996; 105:968.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abramson JS, Giebink GS, Quie PG. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun 1982; 36:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canafax DM, Yuan Z, Chonmaitree T, et al. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr Infect Dis J 1998; 17:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziv O, Kraus M, Holcberg R, et al. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol 2019; 119:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berman S. Otitis media in developing countries. Pediatrics 1995; 96:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Working Group of the Infectious Diseases Society of Southern Africa. Updated guideline for the management of upper respiratory tract infections in South Africa: 2008. South Afr J Epidemiol Infect 2008; 23:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ding Y, Geng Q, Tao Y, et al. Etiology and epidemiology of children with acute otitis media and spontaneous otorrhea in Suzhou, China. Pediatr Infect Dis J 2015; 34:e102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fria TJ, Cantekin EI, Eichler JA. Hearing acuity of children with otitis media with effusion. Arch Otolaryngol 1985; 111:10.
          </a>
         </li>
         <li class="breakAll">
          Bluestone CD, Klein JO. Complications and sequelae: Intratemporal. In: Otitis media in infants an children, 4th ed, BC Decker, Hamilton, ON 2007. p.327.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gawron W, Pośpiech L, Orendorz-Fraczkowska K. An evaluation of postural stability and the effects of middle-ear drainage on vestibulo-spinal reflexes of children with chronic otitis media with effusion. Int J Pediatr Otorhinolaryngol 2004; 68:1175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casselbrant ML, Furman JM, Rubenstein E, Mandel EM. Effect of otitis media on the vestibular system in children. Ann Otol Rhinol Laryngol 1995; 104:620.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golz A, Westerman ST, Gilbert LM, et al. Effect of middle ear effusion on the vestibular labyrinth. J Laryngol Otol 1991; 105:987.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golz A, Angel-Yeger B, Parush S. Evaluation of balance disturbances in children with middle ear effusion. Int J Pediatr Otorhinolaryngol 1998; 43:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J 2000; 19:S37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tähtinen PA, Laine MK, Huovinen P, et al. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med 2011; 364:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med 2011; 364:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sano S, Kamide Y, Schachern PA, Paparella MM. Micropathologic changes of pars tensa in children with otitis media with effusion. Arch Otolaryngol Head Neck Surg 1994; 120:815.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Penido Nde O, Borin A, Iha LC, et al. Intracranial complications of otitis media: 15 years of experience in 33 patients. Otolaryngol Head Neck Surg 2005; 132:37.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6021 Version 36.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23439909" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The diagnosis and management of acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21081729" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24276262" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Trends in otitis media-related health care use in the United States, 2001-2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29720156" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2732519" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28784702" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27918383" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Etiology of Acute Otitis Media in Children Less Than 5 Years of Age: A Pooled Analysis of 10 Similarly Designed Observational Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25545891" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Incidence of otitis media in a contemporary Danish National Birth Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15342850" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Population-based impact of pneumococcal conjugate vaccine in young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30119715" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29958675" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Ambulatory Visits for Otitis Media before and after the Introduction of Pneumococcal Conjugate Vaccination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27182898" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Ten-Year Study of Acute Otitis Media in Rochester, NY.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30770533" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Changes in Otitis Media Episodes and Pressure Equalization Tube Insertions Among Young Children Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Birth Cohort-based Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15121972" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Diagnosis and management of acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26297875" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28763425" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Frequency of Acute Otitis Media in Children Under 24 Months of Age Before and After the Introduction of the 10-valent Pneumococcal Conjugate Vaccine Into the National Immunization Program in Chile.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28657970" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination: A National Observational Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28368738" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29617959" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Reduction in All-Cause Acute Otitis Media in Children&lt;3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33501967" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32773660" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Effect of Social Distancing Due to the COVID-19 Pandemic on the Incidence of Viral Respiratory Tract Infections in Children in Finland During Early 2020.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36638402" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Fluctuations in Pediatric Acute Otitis Media Burden During the First Two COVID-19 Years in Israel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10855564" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Length of the eustachian tube and its postnatal development: computer-aided three-dimensional reconstruction and measurement study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28628951" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Cranial Indicators Identified for Peak Incidence of Otitis Media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10591333" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The heritability of otitis media: a twin and triplet study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17142509" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17671042" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17908769" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24718616" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Polymorphisms of immunity genes and susceptibility to otitis media in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28403045" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Polymorphisms of Mannose-binding Lectin and Toll-like Receptors 2, 3, 4, 7 and 8 and the Risk of Respiratory Infections and Acute Otitis Media in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20394772" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Predisposing factors for acute otitis media in infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27870813" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Acute Otitis Media During Infancy: Parent-reported Incidence and Modifiable Risk Factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8783714" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : A meta-analytic review of the risk factors for acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9577522" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16511750" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16511751" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Otitis media, bacterial colonization, and the smoking parent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29401661" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Air Pollution and Otitis Media in Children: A Systematic Review of Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18562333" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Is pacifier use a risk factor for acute otitis media? A dynamic cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9466224" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25109288" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16033643" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23842949" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8884404" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Prevalence of otitis media, hearing impairment and cerumen impaction among school children in rural and urban Dar es Salaam, Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8884404" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Prevalence of otitis media, hearing impairment and cerumen impaction among school children in rural and urban Dar es Salaam, Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27020793" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Acute Otitis Media and Other Complications of Viral Respiratory Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17764214" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Breastfeeding and maternal and infant health outcomes in developed countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26265016" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Breastfeeding and childhood acute otitis media: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24921688" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The impact of breastfeeding on nasopharyngeal microbial communities in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7971001" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Evidence in infants with cleft palate that breast milk protects against otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19581824" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14962529" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17545372" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18205533" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Association of nasopharyngeal bacterial colonization during upper respiratory tract infection and the development of acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19153302" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Rate of concurrent otitis media in upper respiratory tract infections with specific viruses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16201010" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7845752" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7845752" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27273691" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Ten-Year Study of the Stringently Defined Otitis-prone Child in Rochester, NY.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26953891" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17083014" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20335823" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15361720" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Changes in frequency and pathogens causing acute otitis media in 1995-2003.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18559884" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19935445" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12442021" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Multinational study of pneumococcal serotypes causing acute otitis media in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15361721" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11172176" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19561428" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Bacteriology of spontaneously draining acute otitis media in children before and after the introduction of pneumococcal vaccination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27036355" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17940232" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15909260" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21983212" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19331730" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Novel type of Streptococcus pneumoniae causing multidrug-resistant acute otitis media in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18595984" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36107786" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32067037" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Rising Pneumococcal Antibiotic Resistance in the Post-13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates From a Primary Care Setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34432166" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015-2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27225239" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27997514" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22330166" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22330166" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24911895" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28279564" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26271823" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29570583" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Antibiotic Recommendations for Acute Otitis Media and Acute Bacterial Sinusitis: Conundrum No More.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14699456" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Association of clinical signs and symptoms with bacterial findings in acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11465836" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29200185" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Early Vaccine-type Pneumococcal Acute Otitis Media Does not Predispose to Subsequent Otitis When Compared With Early Acute Otitis Media Due to Other Bacterial Etiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17596798" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Laterality of acute otitis media: different clinical and microbiologic characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17596799" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Is bilateral acute otitis media clinically different than unilateral acute otitis media?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10530598" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34321442" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Haemophilus influenzae Prevalence, Proportion of Capsulated Strains and Antibiotic Susceptibility During Colonization and Acute Otitis Media in Children, 2019-2020.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25175818" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35436266" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Increase in Haemophilus influenzae Detection in 13-Valent Pneumococcal Conjugate Vaccine Immunized Children With Acute Otitis Media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1513611" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Ten-year review of otitis media pathogens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29595417" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Genotypic characterization of Haemophilus influenzae isolates from paediatric patients in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23844235" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Incidence survey of acute otitis media in children in Sado Island, Japan--Sado Otitis Media Study (SADOMS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26093673" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19504729" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15937760" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Acute otitis media caused by Streptococcus pyogenes in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19319018" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27677281" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Acute otitis media with spontaneous tympanic membrane perforation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19628757" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Methicillin-resistant Staphylococcus aureus in middle ear fluid of children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12842372" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34166300" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Prevalence and Antimicrobial Resistance of Bacteria in Children With Acute Otitis Media and Ear Discharge: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12237601" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10460078" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Otitis media in infants aged 0-8 weeks: frequency of associated serious bacterial disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9920949" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Prevalence of various respiratory viruses in the middle ear during acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1852537" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Viruses in acute otitis media: increasing evidence for clinical significance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9685428" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15378427" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Burden of influenza in children in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23249910" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Seasonality of acute otitis media and the role of respiratory viral activity in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23349853" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24891432" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Frequent carriage of resistance mechanisms toβ-lactams and biofilm formation in Haemophilus influenzae causing treatment failure and recurrent otitis media in young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22018357" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Multi-species bacterial biofilm and intracellular infection in otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17083015" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Acute otitis media is not a pure bacterial disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1534364" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Effect of viral respiratory tract infection on outcome of acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2373879" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8195602" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8973284" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7076299" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9493813" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30703661" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7596700" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Otitis media in developing countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Updated guideline for the management of upper respiratory tract infections in South Africa: 2008
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25379833" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Etiology and epidemiology of children with acute otitis media and spontaneous otorrhea in Suzhou, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4038450" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Hearing acuity of children with otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4038450" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Hearing acuity of children with otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15302148" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : An evaluation of postural stability and the effects of middle-ear drainage on vestibulo-spinal reflexes of children with chronic otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7639471" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Effect of otitis media on the vestibular system in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1787379" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Effect of middle ear effusion on the vestibular labyrinth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9596366" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Evaluation of balance disturbances in children with middle ear effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10821471" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Clinical course, complications and sequelae of acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21226577" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : A placebo-controlled trial of antimicrobial treatment for acute otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21226576" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Treatment of acute otitis media in children under 2 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8049041" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Micropathologic changes of pars tensa in children with otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15632907" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Intracranial complications of otitis media: 15 years of experience in 33 patients.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
